Therapy-Related Myelodysplastic Syndrome Recruiting Phase 2 Trials for Antilymphocyte immunoglobulin (horse) (DB09312)

IndicationStatusPhase
DBCOND0079186 (Therapy-Related Myelodysplastic Syndrome)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs